Members of the NCRI Brain Group have published a position statement arguing that there is not enough evidence to support…
NCRI Newsletter | Jan 2021
The impact of COVID-19 on cancer and the safety of cancer surgery during the pandemic.…
Using online symptom reporting to manage cancer symptoms
A trial has found that cancer patients can benefit from regular online symptom reporting combined with a computer algorithm to…
Supporting the development of high-quality research by providing expert guidance
NCRI’s proposals guidance helps investigators develop ideas for cancer research studies and progress them into applications ready for funding. Researchers…
COVIDSurg gathers evidence on the safety of surgery during COVID-19
The COVID-19 pandemic resulted in rapid reductions in elective surgery, including surgery as a treatment for head and neck cancer.…
Identifying lymphoma treatment response using molecular profiling
Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell malignancy and the most common type of non-Hodgkin lymphoma.…
NCRI Newsletter | Nov 2020
The NCRI has unveiled a new brand. The brand reflects our bold ambitions to bring together the brightest scientific and…
Study identifies challenges in involving young people in research
Evaluating specialist care for young people with cancer was identified as a research priority by the NCRI Teenage and Young…
Using knowledge provided by NCRI research funding data to increase the impact of prostate cancer research
Prostate Cancer Research recognised that with a large number of cancer research charities duplication was a possibility and that challenges…
Strengthening the research workforce through NCRI Group membership
Dr Simon Mitchell is a member of the Science Subgroup of the NCRI Lymphoma Group and has recently been awarded…
NCRI Lymphoma Group trainee receives UKRI fellowship
Congratulations to Dr Simon Mitchell, who is a member of the Science Subgroup of the NCRI Lymphoma Group, on being…
Developing one of the most extensive global studies of lung cancer patients
Despite many years of clinical research into lung cancer, the outcomes for patients diagnosed with the disease remain poor. Most…